Sartorius AG
Company Profile
Business description
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Contact
Otto-Brenner-Strasse 20
GottingenNI37079
DEUT: +49 5513080
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
13,573
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,439.10 | 73.40 | 0.88% |
CAC 40 | 7,593.87 | 38.00 | 0.50% |
DAX 40 | 22,496.98 | 71.15 | 0.32% |
Dow JONES (US) | 40,752.96 | 83.60 | 0.21% |
FTSE 100 | 8,496.80 | 1.95 | 0.02% |
HKSE | 22,493.17 | 373.76 | 1.69% |
NASDAQ | 17,710.74 | 264.40 | 1.52% |
Nikkei 225 | 36,717.49 | 265.19 | 0.73% |
NZX 50 Index | 12,311.33 | 162.73 | 1.34% |
S&P 500 | 5,604.14 | 35.08 | 0.63% |
S&P/ASX 200 | 8,218.50 | 72.90 | 0.89% |
SSE Composite Index | 3,279.03 | 7.62 | -0.23% |